Carla Fornari

10PUBLICATIONS
22CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Major global burdens of diseaseTraditional Chinese medicine and treatmentsNanomedicineGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 24, 2026
Decision tree model to assess consequences and costs associated with therapy administration pathways for patients with HER2+ breast cancer in Italian oncological centers.

|Dec 13, 2025
Cost-effectiveness of fenfluramine as add-on treatment in the management of Dravet Syndrome: A real-world multicenter study.

Paolo A Cortesi, Carla Fornari, Alessandra Boncristiano

|Nov 07, 2025
Anti-seizure medications in patients with post-stroke epilepsy: A survival analysis study.

Ippazio Cosimo Antonazzo, Carla Fornari, Gabriele Buongarzone

|Sep 19, 2025
Cost-Consequence Analysis of Natalizumab Compared with Other High-Efficacy Treatments in Patients with Relapsing-Remitting Multiple Sclerosis.

Luca Prosperini, Vincenzo Brescia Brescia Morra, Carla Fornari

|Aug 29, 2024
Generalizability and treatment with sodium-glucose co-trasporter-2 inhibitors (SGLT2i) among patients with type 2 diabetes: an assessment using an Italian primary care database.

Ippazio Cosimo Antonazzo, Davide Rozza, Paolo Angelo Cortesi

|Feb 05, 2024
The value-based healthcare approach to haemophilia: Development of outcome measures for the evaluation of care of people with haemophilia.

Paolo Angelo Cortesi, Carla Fornari, Sara Conti

Pageof 2

Frequent Collaborators

4 joint publications

Sara Conti

3 joint publications

Ippazio Cosimo Antonazzo

3 joint publications

Pietro Ferrara

2 joint publications

Rosa Gini